chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse event; Patient received a 1st dose of the primary series (monovalent) on 18-Apr-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a 1st dose of the primary series (monovalent) on 18-Apr-2023) and NO ADVERSE EVENT (No adverse event) in a 19-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     It was reported that patient had no known conditions and received no other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 18-Apr-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 18-Apr-2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a 1st dose of the primary series (monovalent) on 18-Apr-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a 1st dose of the primary series (monovalent) on 18-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received a 1st dose of the primary series (monovalent) on 18-Apr-2023).    Concomitant drugs were not reported. No other adverse events were reported. Treatment medications were not provided.   This case was linked to MOD-2023-726266 (Patient Link).
I had arm pain in right arm about 5 minutes after. Had a migraine about 30 minutes after For about a week to a week and a half after getting the shot I had pain in both arms in shoulders, elbows, wrists and hands For about 5 days after I had pain in lower back, hips and knees For about 2 weeks after I would get consistent headaches everyday between 9 and 11 AM and 8 and 10 PM.  If I sat to long I would be in pain, if I stood to long I would be in pain.  I don?t get the pains every day but I do get them a few times a week ever since I take Tylenol or ibuprofen for the  pain
breathing on a scale of 2/10; experienced cough almost like having asthma symptoms; fatigue/very tired; very hot; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (very hot), PERIPHERAL SWELLING (swollen arm), DYSPNOEA (breathing on a scale of 2/10), COUGH (experienced cough almost like having asthma symptoms) and FATIGUE (fatigue/very tired) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0010218) for COVID-19 vaccination.     The patient's past medical history included Bee sting on 20-Apr-2021.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 19-Apr-2021, the patient experienced FEELING HOT (very hot), PERIPHERAL SWELLING (swollen arm) and FATIGUE (fatigue/very tired). On 21-Apr-2021, the patient experienced DYSPNOEA (breathing on a scale of 2/10). 21-Apr-2021, the patient experienced COUGH (experienced cough almost like having asthma symptoms). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Bee sting, at an unspecified dose and frequency. On 21-Apr-2021, FEELING HOT (very hot), PERIPHERAL SWELLING (swollen arm) and FATIGUE (fatigue/very tired) outcome was unknown. At the time of the report, DYSPNOEA (breathing on a scale of 2/10) and COUGH (experienced cough almost like having asthma symptoms) outcome was unknown.            Treatment included Benadryl(diphenhydramine) for the event bee sting. No concomitant medications reported.   This case was linked to MOD-2021-083774 (Patient Link).
Chest uncomfortable; increased heart rate; breathing problem; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (Chest uncomfortable), HEART RATE INCREASED (increased heart rate) and DYSPNOEA (breathing problem) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.   No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Chest uncomfortable), HEART RATE INCREASED (increased heart rate) and DYSPNEA (breathing problem). At the time of the report, CHEST DISCOMFORT (Chest uncomfortable), HEART RATE INCREASED (increased heart rate) and DYSPNOEA (breathing problem) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication information was provided. The fresh herbs including mint, basil, Huttuynia, peppermint, bean sprouts, lettuce, and fresh garlic also helped the patient side effects of Moderna vaccine.  No treatment medication was provided.
Got hep B # 1 on 9/4/02. On 9/12/02 presented in office with urticaria. Got hep B #2 on 10/4/02 presented in office 10/17/02 with urticaria (she has been broke out in rash x 5 days now).
On 4/28, patients left thigh became reddened and swollen and hard (area affected 10x8cm) . Treated with Augmentin and Benadryl. (Sibling had similar reaction)
redness, swelling, heat and hard spot at site of injection 24-72 hours after initial injection. Low grade fever of approximately 100 degrees farenheit 48-96 hours after injection. Fussiness 12-96 hours after injection. Inconsolable screaming for 1.5 to 3 hours after 72 hours and continuing daily until day 7. Suspected bulging fontanel from 48-72 hours after injection. Vomiting 72-96 hours after injection. Decreased appetite and refusal to nurse 48-72 hours after injection. Increased sleepiness (12 hours at a time) 72 hours to 96 hours after injection.
fever 99-100.3; headache; sinus pressure andcongestion; sinus pressure andcongestion; low back pain; fatigue; body chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 14:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had allergies to sulpha, amoxicillin, tetracyclines, Levaquin and Augmentin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, liothyronine (THYROID NP) 1.25 grain and new mood supplement (1/night). Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267) via an unspecified route of administration in the left arm on 18Feb2021 at 16:30 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. On 22Mar2021 at 14:00, the patient experienced sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills. On 22Mar2021 at 14:00, the patient underwent lab test which include body temperature which measured 99-100.3. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the events. The clinical outcome of the events sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills were unknown at the time of this report.                  No follow-up attempts possible. No further information expected
received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.  On 18-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date). On 18-Jun-2021, EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information provided.
Flu vaccine 10/10/13 - parent started with runny nose and cough 1245p - coughing worsened patient took BENADRYL from home. Patient took TYLENOL. Patient also reporting lump in throat, chills and difficulty breathing went to sleep at 3p and reports lump in throat persisted.
Hives started within 2 hours (Benadryl), arm hot to touch, elevated heart rate (98 at resting, typically at 58-65), itchiness throughout the body, muscle soreness, severe chills (negative for fever), chest tightness (O2 stat; 97), COVID Arm?.took ibuprofen and it just helped minimize the symptoms but didn?t not take the issues away, welt on arm has grown from last night and is very hot to touch.
p/vax pt devel local rxn that consisted of swelling & cellulitis;f/u from a RN reported that no further info will be provided;
I did not have an adverse reaction to the vaccine. I began not feeling well with a sinus infection on 12/30/2022. I tested positive for COVID-19 on 12/31/2022.  I went to an urgent care, and they gave me two prescriptions. I ended up with a sinus infection, ear infection and COVID-19. As of today, I continue to have difficulty breathing after going upstairs.
SUDDEN HEART ATTACKS; This spontaneous report received from a consumer via social media (J and J Corporate) via a company representative concerned multiple patients (2 male patients) in mid 40s of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patients were healthy. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, 2 to 3 weeks post vaccination the patients died from sudden heart attacks. Reporter stated, "I have (had) 2 friends. Both health mid 40s men...died sudden heart attacks 2-3 weeks post vaccination (poisoned)". It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20221258720-Sudden Heart attack. The event has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.; Reported Cause(s) of Death: HEART ATTACK
1 day p/vax pt devel fever up to 103.8, joint pains, severe h/a, back pain, a very dry cough;despite the administration of APAP, temp 2 days post vax inc to 104 & exp malaise;
Swelling at injection site right arm, circling around arm and moving up toward shoulder. Reddened with heat disbursement.
BP was elevated; feelings poorly with headache; fatigue; Heart rate >100 beats per min; chills; Giant spot on my arm; Serious pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Giant spot on my arm), PAIN IN EXTREMITY (Serious pain), HYPERTENSION (BP was elevated), HEADACHE (feelings poorly with headache) and CHILLS (chills) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Sulfonamide allergy (had rash in childhood) since 01-Jan-1987, Grass allergy (Rash and hives) since 01-Jan-2010, Endometriosis (Endometriosis W HRT) since 01-Jan-2006, Chronic UTI since 01-Jun-2021, Migraine since 01-Jan-2010 and Fragrance sensitivity (Jasmine, had itching) since 01-Jan-2015. Concomitant products included ESTROGEN NOS;TESTOSTERONE from 01-Jan-2013 to an unknown date for Hormone replacement therapy, ERENUMAB (AIMOVIG [ERENUMAB]) from 01-Jan-2019 to an unknown date for Migraine, TIZANIDINE from 01-Jan-2016 to an unknown date for Muscle spasms, BUPROPION HYDROCHLORIDE (WELLBUTRIN SR) from 01-Jan-2008 to an unknown date for Off label use, HYDROMORPHONE from 01-Jan-2010 to an unknown date and METHADONE HYDROCHLORIDE (METHADONE [METHADONE HYDROCHLORIDE]) from 01-Jan-2010 to an unknown date for an unknown indication.    On 23-Sep-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced RASH MACULAR (Giant spot on my arm) and PAIN IN EXTREMITY (Serious pain). On 22-Oct-2021, the patient experienced CHILLS (chills) and HEART RATE INCREASED (Heart rate >100 beats per min). On an unknown date, the patient experienced HYPERTENSION (BP was elevated), HEADACHE (feelings poorly with headache) and FATIGUE (fatigue). At the time of the report, RASH MACULAR (Giant spot on my arm), PAIN IN EXTREMITY (Serious pain), HEADACHE (feelings poorly with headache), CHILLS (chills) and HEART RATE INCREASED (Heart rate >100 beats per min) had resolved and HYPERTENSION (BP was elevated) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Hydromorphone and methadone indication was given as ENDO.  Patient is on OPIATE C2 (Multivitamin) takes orally for endometriosis pain since from 01-Jan-2010 (still taking) and FIORINOL takes orally for migraine since from 01-Jan-2013 (still taking).  No treatment medications were reported.   This case was linked to MOD-2021-382911 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Dec-2021: Follow up received and medical history updated, added concomitant medications and event  heart rate increased were updated.
CHIEF COMPLAINT:   PT states having increased congestion and blood in stool over the last week.  poor appietite.  and diarrhea   HISTORY OF PRESENT ILLNESS:     88 years old male with past medical history of BPH, hypertension, hyperlipidemia, atrial fibrillation, atopic dermatitis, chronic kidney disease, patient presents to the ER complaining of excessive weakness, shortness of breath, COVID-19 screening was positive in the ER.  Patient admits to cough productive of clear sputum, he denies fever, admits poor appetite.  Patient denies chest pain, no lightheadedness or dizziness.
The patient acknowledged he was getting a pfizer shot but after the shot his wife said they wanted to shingrix instead. Tech and I both understood he wanted pfizer and was told it was his first shot but actually it was his fourth. his consent form does say shingles shot. I specifically asked if he was getting pfizer and he said yes. The patient was understanding and will return in a month for his first shingles shot.
mom called clinic 3JUN98 & states pt was having reaction to shots recv 27MAY98;sx vague & states not acting like self;advised to take child to ER & let nurse know results;
Information has been received from a nurse practitioner concerning a patient who on 17-DEC-2009 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck) due to a human error. There were no adverse effects reported. It was unknown if the patient had sought medical attention. At the time of report the patient's status was unknown. On 20-JAN-2010 all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
I felt a strange taste in my mouth my heart started racing, and my body felt as if it was shaking on the inside. I feel weak and it feels like flu systems my body feels ache.
Within a couple of hours extreme pain at injection site. Within 24 hours feeling like getting sick. Between 36- 45 hours outbreak on shoulder on same side of injection then also around injection site.
Arm soreness; Fever; Chills; Headache; Fatigue; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 030L20A) for COVID-19 vaccination.     The patient's medical history was not reported.  Concomitant products included METFORMIN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form and PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Arm soreness), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt reports that the site was red, hot and the area was approximately 4 in X 7 in, dark red in the center and lighter red to the dimensions and the area was also hard.
2 days after injection I became ill. High temp. up to 103, (flu shot was 10/13/14). On 10/22/14 I went to Dr. She didn't let me go home, took me to Emergency. They put me in hospital for 3 days. Said I had pneumonia or bronchitis.
Hospitalized 1/18/2022; COVID-19 positive 01/19/2022; fully vaccinated   Admission Date: 1/18/2022 Discharge Date: 01/20/2022  Discharge Disposition: Home PRESENTING PROBLEM: Weakness   HOSPITAL COURSE: Patient is an 82-year-old male who was admitted on 01/18/2022 for observation due to generalized weakness secondary to COVID-19 infection.  Patient has not become hypoxic and required no remdesivir, steroids, or MAB given.  He has worked well with PT/OT or recommending home health care.   DM type 2 He has been noted to have hypoglycemic events his Lantus has been reduced down from home 74 units to 50 units recommending this be reduced even further to 40 at discharge.  Patient states he uses a sliding scale at home and not the 28 units 3 times a day.  Reiterated that he continue to use the sliding scale and appropriate scaling chart given to him at discharge.   Patient is ready to go home, family are able to take care of him and give 24 hours supervision, PT/OT feel he is safe for home health care.  Vitals are stable medically clear for discharge.
Acute - chronic arm/shoulder pain. Symptoms have lasted over 3 months. NSAIDs taken PO are helpful. Gradual improvement. Continue to have decreased range of motion, weakness, and intermittent pain.
get sick everytime; Initial information received on 07-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient) via Social media.  This case involved an adult patient of an unknown age and gender who get sick everytime (Illness), after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient get sick everytime (illness) as the patient get the flu shot. The patient did not get it again.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was reported as unknown.  There will be no information available on the batch number for this case.
The next day after receiving the vaccine, I felt flu like systems for about eight hours. On 10/15/2022, about a couple of hours after eating a yogurt I had acute gastrointestinal issues. I felt like I had food poisoning. On 10/19/2022, I had gastrointestinal issues again with tightness in my upper stomach area. I had belching, flatulence and extreme discomfort. I went to an urgent care center and was prescribed pantoprazole and sucralfate for my symptoms. I am scheduled for an endoscopy in January 2023.
This spontaneous report as received from a pharmacy technician refers to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 24-JUL-2017, the patient was vaccinated with improperly stored PNEUMOVAX 23 (lot # M042324, expiration date 10-JUN-2018, dose and route not reported) for prophylaxis. The vaccine was improperly stored at -5.2 degrees Celsius for 7 hours (6 cycles). There was no previous temperature excursion. Data logger was involved. No adverse effects were reported.
Supraventricular tachycardia beginning at approximately 7:30am local time. Heartrate at beginning in upper 150s/lower 160s. Episode has continued for more than one hour, and still continues at this time of writing. Average heartrate of 139 over past hour with 43 readings (both measured manually at the carotid and electronically using finger sensor while in the supine position). Highest reading was 164, lowest reading was 119. Last reading above 150 was at 8:22am local time. Last reading above 130 was at 8:32am local time. Current time is 8:58am.  Prior to episode, no lightheadedness noted. Following beginning of episode, increasing lightheadedness. Moderate headache prior to episode; unsure if episode has exacerbated or not.
Patient developed MIS-C (fever, rash, abdominal pain, eye changes, extremity changes, myocarditis). Symptoms starting  Jan 23, 2022. Had laparoscopic appendectomy 1/28/2022 then developed cardiogenic shock. Currently recovering after anti-inflammatory treatment.
No additional adverse events reported; an expired dose of ROTATEQ was administered today; This spontaneous report was received from a medical assistance regarding a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies were not provided.  On 28-JUN-2021 (reported as "today"), the patient was vaccinated with 1 expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot number 1660992 has been verified to be valid, expiration date reported and validated as 30-APR-2021; vaccination scheme frequency was not reported) via oral route for prophylaxis (expired product administered). It was also reported that Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was properly stored up through the time of administration.